PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2021.008152021394304-314Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resectionAbhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Naranghttp://e-roj.org/upload/pdf/roj-2021-00815.pdf, http://e-roj.org/journal/view.php?doi=10.3857/roj.2021.00815, http://e-roj.org/upload/pdf/roj-2021-00815.pdf
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2021.07.42620211113e70KRAS and NOTCH1/2 Mutations are Associated With Pathologic and Clinical Outcomes in Localized Pancreatic Cancer Treated With Neoadjuvant Chemotherapy and Stereotactic Body Radiotherapy Followed by Surgical ExplorationA.V. Reddy, C. Hill, S. Sehgal, D. Ding, L. Zheng, J. He, J.M. Herman, J.J. Meyer, A. Naranghttps://api.elsevier.com/content/article/PII:S0360301621012967?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301621012967?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2012.07.8382012843S319-S320Pathologic Response With Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic CancerM.S. Rajagopalan, D.E. Heron, H.J. Zeh, A.J. Moser, A.M. Krasinskas, A.E. Quinn, S.A. Burtonhttps://api.elsevier.com/content/article/PII:S0360301612017828?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301612017828?httpAccept=text/plain
Annals of Surgical Oncology10.1245/s10434-021-11202-820222942456-2468Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative ToxicityColin S. Hill, Lauren M. Rosati, Chen Hu, Wei Fu, Shuchi Sehgal, Amy Hacker-Prietz, Christopher L. Wolfgang, Matthew J. Weiss, Richard A. Burkhart, Ralph H. Hruban, Ana De Jesus-Acosta, Dung T. Le, Lei Zheng, Daniel A. Laheru, Jin He, Amol K. Narang, Joseph M. Hermanhttps://link.springer.com/content/pdf/10.1245/s10434-021-11202-8.pdf, https://link.springer.com/article/10.1245/s10434-021-11202-8/fulltext.html, https://link.springer.com/content/pdf/10.1245/s10434-021-11202-8.pdf
Journal of Modern Oncology10.26442/18151434.2021.2.2008692021232300-306Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancerKamil D. Dalgatov, Nikolai N. Semenov, Margarita V. Kozodaevahttps://modernonco.orscience.ru/1815-1434/article/viewFile/58098/pdf, https://modernonco.orscience.ru/1815-1434/article/viewFile/58098/pdf
Pancreatology10.1016/j.pan.2019.05.291201919S110Clinical outcomes of conversion surgery after neoadjuvant chemotherapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer: A single-center, retrospective analysisSang Hyun Shin, Changhoon Yoo, Jaewoo Kwonhttps://api.elsevier.com/content/article/PII:S1424390319303941?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1424390319303941?httpAccept=text/plain
HPB10.1016/j.hpb.2020.11.00420212371072-1083Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancerSara J. Zakem, Adam C. Mueller, Cheryl Meguid, Robert J. Torphy, Douglas E. Holt, Tracey Schefter, Wells A. Messersmith, Martin D. McCarter, Marco Del Chiaro, Richard D. Schulick, Karyn A. Goodmanhttps://api.elsevier.com/content/article/PII:S1365182X20312302?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X20312302?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2016.06.10072016962E165Predictors and Survival for Pathologic Tumor Response Grade in Borderline Resectable and Locally Advanced Pancreatic Cancer Treated With Induction Chemotherapy and Neoadjuvant Stereotactic Body Radiation TherapyE.A. Mellon, S.E. Hoffe, J.M. Frakes, T. Strom, G.M. Springett, R. Shridhar, B.A. Centeno, M.P. Malafa, M.D. Chuong, P.J. Hodulhttps://api.elsevier.com/content/article/PII:S0360301616313335?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301616313335?httpAccept=text/plain
Pancreatology10.1016/j.pan.2021.01.0082021213564-572Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinomaYoshiaki Murakami, Naoya Nakagawa, Naru Kondo, Yasushi Hashimoto, Kenjiro Okada, Shingo Seo, Hiroyuki Otsukahttps://api.elsevier.com/content/article/PII:S1424390321000326?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1424390321000326?httpAccept=text/plain
HPB10.1016/j.hpb.2021.01.00320212381285-1295Prognostic significance of residual lymphovascular invasion after resection of locally advanced and borderline resectable pancreatic adenocarcinomas treated by neoadjuvant chemotherapyPietro Addeo, Antonin Fattori, Caroline Grunder, Patrick Dufour, Gerlinde Averous, Philippe Bachellierhttps://api.elsevier.com/content/article/PII:S1365182X21000046?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X21000046?httpAccept=text/plain